Subaru of America Dedicates June to Sharing Hope and Warmth with Those Battling Cancer
Posted On: June 1, 2021 Read More
The Leukemia & Lymphoma Society launches Impact Research grants to help underserved patients access to clinical trials
Posted On: May 6, 2021Collaborations with Mayo Clinic, Vanderbilt University Medical Center and Weill Cornell Medicine will Increase Representation of Geographically, Ethnically and Economically Underserved Communities in Clinical Trials
Read More
Covid-19 Vaccine Safety Among Blood Cancer Patients
Posted On: April 23, 2021Background and Purpose
Because of the health emergency created by the COVID-19 virus, three COVID-19 vaccinations have been authorized by the U.S. FDA for Emergency Use Administration (EUA). The vaccine clinical trials were streamlined and essentially excluded people with a current or past diagnosis of cancer. Therefore, how people with blood cancer respond to the COVID-19 vaccinations is unknown.
Read More
LLS TAP announces five new investments supporting next generation immunotherapies
Posted On: April 22, 2021RYE BROOK, N.Y., April 22, 2021 /PRNewswire/ -- The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) today announced five new investments aimed at speeding the development of new and improved immunotherapies for the treatment of blood cancers. LLS has dedicated more than $100 million over the past several decades, through both grants and TAP investments, to advancing pioneering approaches that harness cellular immunotherapies to fight blood cancers.
Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.